[1]
2025. Reasons of treatment switching from first generation to second and third generations of TKIs among CML patients in Iraq -Kurdistan region from 2014-2024. Journal of Carcinogenesis. 24, 8s (Oct. 2025), 360–368. DOI:https://doi.org/10.64149/J.Carcinog.24.8s.360-368.